LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
68.55
-5.25 (-7.11%)
Oct 21, 2026, 3:54 PM HKT
| Market Cap | 5.23B |
| Revenue (ttm) | n/a |
| Net Income | -249.58M |
| EPS | -4.04 |
| Shares Out | 76.32M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 139,250 |
| Open | 73.80 |
| Previous Close | 73.80 |
| Day's Range | 68.55 - 77.50 |
| 52-Week Range | 68.55 - 165.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |